136 related articles for article (PubMed ID: 20408077)
21. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature.
Jones R; Rhee DJ
Curr Opin Ophthalmol; 2006 Apr; 17(2):163-7. PubMed ID: 16552251
[TBL] [Abstract][Full Text] [Related]
22. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Hyman L; Heijl A;
Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
[TBL] [Abstract][Full Text] [Related]
23. Acetylsalicylic acid does not reduce the intraocular pressure variation in ocular hypertension or glaucoma.
Lindén C; Alm A
Exp Eye Res; 2000 Mar; 70(3):281-3. PubMed ID: 10712814
[TBL] [Abstract][Full Text] [Related]
24. Incorporating corneal pachymetry into the management of glaucoma.
Iester M; Mete M; Figus M; Frezzotti P
J Cataract Refract Surg; 2009 Sep; 35(9):1623-8. PubMed ID: 19683164
[TBL] [Abstract][Full Text] [Related]
25. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
26. [Early postoperative spikes of the intraocular pressure (IOP) following phacoemulsification in late-stage glaucoma].
Dietlein TS; Jordan J; Dinslage S; Lüke C; Krieglstein GK
Klin Monbl Augenheilkd; 2006 Mar; 223(3):225-9. PubMed ID: 16552655
[TBL] [Abstract][Full Text] [Related]
27. The gradient of retinal functional changes during acute intraocular pressure elevation.
Bui BV; Edmunds B; Cioffi GA; Fortune B
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):202-13. PubMed ID: 15623775
[TBL] [Abstract][Full Text] [Related]
28. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
[TBL] [Abstract][Full Text] [Related]
29. Graves' orbitopathy: frequency of ocular hypertension and glaucoma.
da Silva FL; de Lourdes Veronese Rodrigues M; Akaishi PM; Cruz AA
Eye (Lond); 2009 Apr; 23(4):957-9. PubMed ID: 18535600
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
Chan HC; Chang RC; Koon-Ching Ip A; Chiu K; Yuen WH; Zee SY; So KF
Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
[TBL] [Abstract][Full Text] [Related]
31. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology.
Dueker DK; Singh K; Lin SC; Fechtner RD; Minckler DS; Samples JR; Schuman JS
Ophthalmology; 2007 Sep; 114(9):1779-87. PubMed ID: 17822980
[TBL] [Abstract][Full Text] [Related]
32. Impact of intraocular pressure on venous outflow from the globe: a hypothesis regarding IOP-dependent vascular damage in normal-tension and hypertensive glaucoma.
Bito LZ
J Glaucoma; 1996 Apr; 5(2):127-34. PubMed ID: 8795745
[TBL] [Abstract][Full Text] [Related]
33. Optic disc diameter increases during acute elevations of intraocular pressure.
Poostchi A; Wong T; Chan KC; Kedzlie L; Sachdev N; Nicholas S; Garway-Heath DF; Wells AP
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2313-6. PubMed ID: 19907027
[TBL] [Abstract][Full Text] [Related]
34. Intraocular pressure change in orbital disease.
Nassr MA; Morris CL; Netland PA; Karcioglu ZA
Surv Ophthalmol; 2009; 54(5):519-44. PubMed ID: 19682621
[TBL] [Abstract][Full Text] [Related]
35. Screening for vascular risk factors in glaucoma: the GVRF study.
Zeyen T;
Bull Soc Belge Ophtalmol; 2005; (298):53-60. PubMed ID: 16422222
[TBL] [Abstract][Full Text] [Related]
36. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
38. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
[TBL] [Abstract][Full Text] [Related]
39. Clinical analysis of 106 cases with elevated intraocular pressure in thyroid-associated ophthalmopathy.
He J; Wu Z; Yan J; Yang H; Mao Y; Ai S; Chen Z
Yan Ke Xue Bao; 2004 Mar; 20(1):10-4. PubMed ID: 15124526
[TBL] [Abstract][Full Text] [Related]
40. A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma.
Realini TD
Ophthalmology; 2009 Jul; 116(7):1237-42. PubMed ID: 19576495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
